Jean-Yves Goujon

Title: The Innovative Contributions of Jean-Yves Goujon

Introduction

Jean-Yves Goujon is a notable inventor based in Derval, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for medical applications. With a total of 2 patents to his name, Goujon's work focuses on enhancing drug efficacy and treatment options for various medical conditions.

Latest Patents

Goujon's latest patents include the invention of hydrosoluble hydroxybisphosphonic derivatives of doxorubicin. This invention relates to hydrosoluble hydroxybisphosphonic derivatives of doxorubicin and their pharmaceutically acceptable salts. The compounds are particularly useful in treating bone tumors. Additionally, he has developed bifunctional hydroxy-bisphosphonic acid derivatives, which include methods for production, pharmaceutical compositions, and their use as medicaments.

Career Highlights

Jean-Yves Goujon is currently associated with Atlanthera, a company dedicated to advancing pharmaceutical innovations. His work at Atlanthera has allowed him to focus on the synthesis and application of novel compounds that have the potential to improve patient outcomes.

Collaborations

Goujon collaborates with talented individuals in his field, including Ronan Le Bot and Maxim Egorov. These collaborations enhance the research and development efforts at Atlanthera, fostering an environment of innovation and discovery.

Conclusion

Jean-Yves Goujon's contributions to pharmaceutical inventions demonstrate his commitment to advancing medical science. His innovative patents and collaborative efforts position him as a key figure in the field of drug development.